MISSION Therapeutics Company
Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas
Founded Date:
2011
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Technology:
Cancer
Employee Number:
11-50
Industry:
Mitochondrial Dynamics
Estimated Revenue:
$10M to $50M
Number Of Exists:
N/A
Funding Status:
Late Stage Venture
Investor Type:
N/A
Investment Stage:
N/A